Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2018 May 1:1352458518779925. doi: 10.1177/1352458518779925. [Epub ahead of print]

PMID:
29862891
2.

Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.

Nakken O, Lindstrøm JC, Holmøy T.

J Neurol. 2018 Jun;265(6):1295-1302. doi: 10.1007/s00415-018-8832-9. Epub 2018 Mar 21.

PMID:
29564602
3.

Severe multiple sclerosis reactivation after gonadotropin treatment.

Torkildsen Ø, Holmøy T, Myhr KM.

Mult Scler Relat Disord. 2018 May;22:38-40. doi: 10.1016/j.msard.2018.02.031. Epub 2018 Mar 6.

PMID:
29525298
4.

Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):303-310. doi: 10.1080/21678421.2017.1418004. Epub 2017 Dec 22.

PMID:
29271248
5.

Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F.

Ann Clin Transl Neurol. 2017 Sep 27;4(10):756-761. doi: 10.1002/acn3.451. eCollection 2017 Oct.

6.

In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.

Høglund RA, Lossius A, Johansen JN, Homan J, Benth JŠ, Robins H, Bogen B, Bremel RD, Holmøy T.

Front Immunol. 2017 Oct 2;8:1255. doi: 10.3389/fimmu.2017.01255. eCollection 2017.

7.

July 2017 ENCALS statement on edaravone.

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. No abstract available.

PMID:
28975816
8.

An update on cladribine for relapsing-remitting multiple sclerosis.

Holmøy T, Torkildsen Ø, Myhr KM.

Expert Opin Pharmacother. 2017 Oct;18(15):1627-1635. doi: 10.1080/14656566.2017.1372747. Epub 2017 Sep 11. Review.

PMID:
28858531
9.

Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies.

Holmøy T, von der Lippe H, Leegaard TM.

BMC Neurol. 2017 Apr 4;17(1):65. doi: 10.1186/s12883-017-0848-8.

10.

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT.

BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0.

11.

Re: Familieplanlegging, graviditet og amming ved multippel sklerose.

Holmøy T, Torkildsen Ø.

Tidsskr Nor Laegeforen. 2017 Feb 21;137(4):259. doi: 10.4045/tidsskr.17.0054. eCollection 2017 Feb. Norwegian. No abstract available.

PMID:
28225223
Free Article
12.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A, Nordin F, Ludolph AC, Weishaupt JH, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirth C, Holmøy T, Morita M, Tysnes OB, Benatar M, Wuu J, Lange DJ, Bisgård C, Asgari N, Tarvainen I, Brännström T, Andersen PM.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):256-264. doi: 10.1080/21678421.2016.1262423. Epub 2016 Dec 12.

PMID:
27936955
13.
14.

Family planning, pregnancy and breastfeeding in multiple sclerosis.

Holmøy T, Torkildsen Ø.

Tidsskr Nor Laegeforen. 2016 Nov 8;136(20):1726-1729. eCollection 2016 Nov. Review. English, Norwegian.

15.
16.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
17.

Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study.

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T.

J Neurol. 2016 Dec;263(12):2378-2385. Epub 2016 Sep 1.

PMID:
27586392
18.

No association of tobacco use and disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. doi: 10.1212/NXI.0000000000000260. eCollection 2016 Aug.

19.

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T.

Mult Scler. 2017 Mar;23(3):395-402. doi: 10.1177/1352458516654310. Epub 2016 Jul 11.

PMID:
27325604
20.

High-throughput sequencing of immune repertoires in multiple sclerosis.

Lossius A, Johansen JN, Vartdal F, Holmøy T.

Ann Clin Transl Neurol. 2016 Feb 25;3(4):295-306. doi: 10.1002/acn3.295. eCollection 2016 Apr. Review.

21.

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.

Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21.

PMID:
26998820
22.

Re: Kronisk utmattelsessyndrom/myalgisk encefalopati--sykdomsmekanismer, diagnostikk og behandling.

Holmøy T.

Tidsskr Nor Laegeforen. 2016 Feb 9;136(3):204-5. doi: 10.4045/tidsskr.16.0051. eCollection 2016 Feb 9. Norwegian. No abstract available.

23.

Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?

Holmøy T, Torkildsen Ø.

Expert Rev Neurother. 2016;16(3):233-5. doi: 10.1586/14737175.2016.1146134. Epub 2016 Feb 12. No abstract available.

PMID:
26796244
24.

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.

Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A.

Genes Immun. 2016 Mar;17(2):118-27. doi: 10.1038/gene.2015.61. Epub 2016 Jan 14.

25.

Body mass index influence interferon-beta treatment response in multiple sclerosis.

Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø.

J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26.

PMID:
26531700
26.

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T.

J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1.

PMID:
26429571
27.

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.

Beiske GA, Holmøy T, Beiske AG, Johannessen SI, Johannessen Landmark C.

Mult Scler Int. 2015;2015:317859. doi: 10.1155/2015/317859. Epub 2015 Jun 29.

28.

Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.

Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T.

Clin Immunol. 2015 Oct;160(2):211-25. doi: 10.1016/j.clim.2015.06.001. Epub 2015 Jun 6.

PMID:
26055752
29.

Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.

Helland CB, Holmøy T, Gulbrandsen P.

Int J MS Care. 2015 May-Jun;17(3):122-9. doi: 10.7224/1537-2073.2014-007.

30.

WT1 and interferon-β-vitamin D association in MS: a longitudinal study.

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.

Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448. Epub 2015 Jun 2.

PMID:
26037530
31.

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.

Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26.

32.

Impact of the environment on multiple sclerosis.

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T.

Tidsskr Nor Laegeforen. 2015 May 19;135(9):856-60. doi: 10.4045/tidsskr.14.0751. eCollection 2015 May 19. Review. English, Norwegian.

33.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

34.

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2015 Dec;21(14):1856-64. doi: 10.1177/1352458515578770. Epub 2015 May 6.

35.

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11.

PMID:
25773151
36.

Unstable terminality: negotiating the meaning of chronicity and terminality in motor neurone disease.

Lerum SV, Solbraekke KN, Holmøy T, Frich JC.

Sociol Health Illn. 2015 Jan;37(1):81-96. doi: 10.1111/1467-9566.12182.

PMID:
25601066
37.

Iron and copper in progressive demyelination--New lessons from Skogholt's disease.

Aspli KT, Flaten TP, Roos PM, Holmøy T, Skogholt JH, Aaseth J.

J Trace Elem Med Biol. 2015;31:183-7. doi: 10.1016/j.jtemb.2014.12.002. Epub 2014 Dec 15.

PMID:
25563774
38.

The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.

Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV.

Exp Neurol. 2015 Mar;265:8-21. doi: 10.1016/j.expneurol.2014.12.015. Epub 2014 Dec 24.

39.

[Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support].

Holmøy T, Myhr KM, Bø L.

Tidsskr Nor Laegeforen. 2014 Dec 9;134(23-24):2239-40. doi: 10.4045/tidsskr.14.1458. eCollection 2014 Dec 9. Norwegian. No abstract available.

40.

Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.

Vego H, Sand KL, Høglund RA, Fallang LE, Gundersen G, Holmøy T, Maghazachi AA.

Cell Mol Immunol. 2016 Jan;13(1):57-64. doi: 10.1038/cmi.2014.114. Epub 2014 Dec 1.

41.

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 May;1(5):376-7. doi: 10.1002/acn3.56. Epub 2014 Apr 10. No abstract available.

42.

Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 Feb;1(2):141-4. doi: 10.1002/acn3.37. Epub 2014 Feb 4.

43.

Shared decision-making in decisions on treatment.

Gulbrandsen P, Ofstad EH, Holmøy T, Vandvik PO.

Tidsskr Nor Laegeforen. 2014 Sep 16;134(17):1670-2. doi: 10.4045/tidsskr.14.0239. eCollection 2014 Sep 16. English, Norwegian. No abstract available.

44.

Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM.

Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2.

PMID:
25182290
45.

High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.

Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J.

Eur J Immunol. 2014 Nov;44(11):3439-52. doi: 10.1002/eji.201444662. Epub 2014 Sep 16.

46.

Approach to bone protection in multiple sclerosis.

McKenna MJ, Holmøy T.

Eur J Neurol. 2015 Apr;22(4):601-2. doi: 10.1111/ene.12504. Epub 2014 Jul 2. No abstract available.

PMID:
24986035
47.

[Re: Vitamin D--how much is enough, and is more better for your health?].

Holmøy T, Løken-Amsrud K, Kampman MT, Torkildsen Ø, Myhr KM.

Tidsskr Nor Laegeforen. 2014 May 27;134(10):1024-5. doi: 10.4045/tidsskr.14.0618. eCollection 2014 May 27. Norwegian. No abstract available.

48.

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O.

Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19.

PMID:
24842958
49.

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2014 Jun 15;271(1-2):60-5. doi: 10.1016/j.jneuroim.2014.03.014. Epub 2014 Mar 24.

PMID:
24713402
50.

Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M.

Mult Scler. 2014 Jul;20(8):1042-9. doi: 10.1177/1352458513513968. Epub 2014 Jan 10.

PMID:
24414538

Supplemental Content

Loading ...
Support Center